Inventor
ROUSH WILLIAM R
US29 patents
⚠️ This page may combine multiple inventors who share the name “ROUSH WILLIAM R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNATE TUMOR IMMUNITY INC
12 patentsUS10556903B2Feb 11, 2020
NLRP3 modulators
INNATE TUMOR IMMUNITY INC12 citations85
US10604542B2Mar 31, 2020
Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
INNATE TUMOR IMMUNITY INC5 citations83
US10533005B2Jan 14, 2020
NLRP3 modulators
INNATE TUMOR IMMUNITY INC9 citations83
US11344543B2May 31, 2022
NLRP3 modulators
INNATE TUMOR IMMUNITY INC2 citations72
US10961270B2Mar 30, 2021
Compounds and compositions for treating conditions associated with sting activity
INNATE TUMOR IMMUNITY INC2 citations72
US12351580B2Jul 8, 2025
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US12171756B2Dec 24, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US11827632B2Nov 28, 2023
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations62
US11505571B2Nov 22, 2022
Compounds and compositions for treating conditions associated with sting activity
INNATE TUMOR IMMUNITY INC0 citations62
US11072612B2Jul 27, 2021
NLRP3 modulators
INNATE TUMOR IMMUNITY INC1 citations62
US12037344B2Jul 16, 2024
NLRP3 modulators
INNATE TUMOR IMMUNITY INC0 citations51
US10723756B2Jul 28, 2020
Cyclic dinucleotides for treating conditions associated with STING activity such as cancer
INNATE TUMOR IMMUNITY INC0 citations51
SCRIPPS RESEARCH INST
5 patentsUS10851113B2Dec 1, 2020
Heterocyclic inhibitors of monocarboxylate transporters
SCRIPPS RESEARCH INST1 citations68
US10329303B2Jun 25, 2019
Heterocyclic inhibitors of monocarboxylate transporter
SCRIPPS RESEARCH INST2 citations68
US11666578B2Jun 6, 2023
Small molecule inhibitors of CDK12/CDK13
SCRIPPS RESEARCH INST0 citations47
US9493464B2Nov 15, 2016
Wee1 degradation inhibitors
SCRIPPS RESEARCH INST2 citations39
US10603322B2Mar 31, 2020
Therapeutic targeting of casein kinase 1δ in breast cancer
SCRIPPS RESEARCH INST0 citations33
NOVARTIS AG
5 patentsUS11760735B2Sep 19, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US11597706B2Mar 7, 2023
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US11339136B2May 24, 2022
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations62
US11447460B2Sep 20, 2022
Compounds and compositions for treating conditions associated with NLRP activity
NOVARTIS AG0 citations52
US11718631B2Aug 8, 2023
Sulphonamides and compositions thereof for treating conditions associated with NLRP activity
NOVARTIS AG0 citations51
UNIV FLORIDA
3 patentsUS11560389B2Jan 24, 2023
Heterocyclic inhibitors of monocarboxylate transporters
UNIV FLORIDA0 citations57
US11731934B2Aug 22, 2023
HDAC inhibitor compounds and methods of treatment
UNIV FLORIDA0 citations54
US10807944B2Oct 20, 2020
HDAC inhibitor compounds and methods of treatment
UNIV FLORIDA1 citations54